OSE Immunotherapeutics SA
PAR:OSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OSE Immunotherapeutics SA
PAR:OSE
|
FR |
|
Grifols SA
MAD:GRF
|
ES |
|
M
|
MHP Hotel AG
XMUN:CDZ0
|
DE |
|
A
|
Anglo American PLC
SIX:AAM
|
UK |
|
T
|
Tenaris SA
F:TW1
|
LU |
|
T
|
Trailblazer Merger Corporation I
NASDAQ:TBMC
|
US |
|
A
|
ASML Holding NV
XMUN:ASME
|
NL |
|
E
|
Electricite de France SA
F:E2F
|
FR |
|
K
|
Kyowa Kirin Co Ltd
F:KY4
|
JP |
|
Direct Communication Solutions Inc
OTC:DCSX
|
US |
|
Y
|
Yamini Investments Company Ltd
BSE:511012
|
IN |
|
C
|
China Telecom Corp Ltd
XMUN:ZCH
|
CN |
|
T
|
Technical Olympic SA
ATHEX:OLYMP
|
GR |
|
AlJazira REIT
SAU:4331
|
SA |
|
C
|
Caterpillar Inc
F:CAT1
|
US |
|
P
|
PetroVietnam Fertilizer and Chemicals Corp
VN:DPM
|
VN |
|
L
|
Lennar Corp
XBER:LNN
|
US |
|
Express Inc
OTC:EXPRQ
|
US |
Wall St Price Targets
OSE Price Targets Summary
OSE Immunotherapeutics SA
According to Wall Street analysts, the average 1-year price target for
OSE is 13.464 EUR with a low forecast of 8.282 EUR and a high forecast of 22.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OSE's stock price target?
Price Target
13.464
EUR
According to Wall Street analysts, the average 1-year price target for
OSE is 13.464 EUR with a low forecast of 8.282 EUR and a high forecast of 22.05 EUR.
What is the Revenue forecast for OSE Immunotherapeutics SA?
Projected CAGR
234%
The compound annual growth rate for Revenue over the next 3 years is 234%.